• Science and Research

  Mylan Approved to Market CF Treatments in UK

  Posted by cystic-fibrosis-news-moderator on August 1, 2019 at 9:16 am

  

  Mylan has been granted rights to market in the U.K. TOBI Solution and TOBI Podhaler to treat P. aeruginosa lung infections in cystic fibrosis patients. Read more here.

  How do you feel about this news?

  cystic-fibrosis-news-moderator replied 4 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply